Letter to the Editor
Occurrence of five distinct red cell alloantibodies in a renal transplant recipient: Diagnostic and therapeutic implications of minor histocompatibility antigens (Kidd and Duffy) for renal allograft outcome
Rajeswari Subramaniyan,
Rajeswari Subramaniyan
Department of Transfusion Medicine, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India
Search for more papers by this authorRajeswari Subramaniyan,
Rajeswari Subramaniyan
Department of Transfusion Medicine, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India
Search for more papers by this author
References
- 1Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol 2012; 23: 1631–4.
- 2Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46: 630–5.
- 3Koermoeczi GF, Mayr WR. Responder individuality in red blood cell alloimmunization. Transfus Med Hemother 2014; 41: 446–51.
- 4Blumberg N, Peck K, Ross K, Avila E. Immune response to chronic red blood cell transfusion. Vox Sang 1983; 44: 212–7.
- 5Habibi B, Lecolier B. Limited indications for phenotyped blood in the prevention of transfusion-induced anti-red blood cell alloimmunization in chronic kidney failure. Nephrologie 1983; 4: 279–82.
- 6Blumberg N, Ross K, Avila E, Peck K. Should chronic transfusions be matched for antigens other than ABO and Rho(D)? Vox Sang 1984; 47: 205–8.
- 7Domen RE, Ramirez G. Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis. Nephron 1988; 48: 284–5.
- 8Katoh S, Ida K, Mizunoya A. Irregular isoantibodies in the sera of patients undergoing chronic hemodialysis. Int J Artif Organs 1991; 14: 136–40.
- 9Angulo IL, Lima EG. Antierythrocyte antibodies in hemodialysis and kidney transplant patients. Ren Fail 1999; 21: 483–6.
- 10Shukla JS, Chaudhary RK. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis. Indian J Pathol Microbiol 1999; 42: 299–302.
- 11Thakral B, Saluja K, Sharma RR, Marwaha N. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Hematology 2008; 13: 313–8.
- 12da Silva SF, Ferreira GM, da Silva SL, Alves TM, Ribeiro IF, Ribeiro TR, et al. Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation. Rev Bras Hematol Hemoter 2013; 35: 185–8.
- 13Babiker HA, Elsayed TY. Frequency of Alloantibodies among chronic renal failure patients in red sea state. Indian J Hematol Blood Transfus 2014; 30: 187–90.
- 14Gehrie EA, Tormey CA. The influence of clinical and biological factors on transfusion-associated non-ABO antigen alloimmunization: responders, hyper-responders, and non-responders. Transfus Med Hemother 2014; 41: 420–9.
- 15Tanhehco YC, Berns JS. Red blood cell transfusion risks in patients with end-stage renal disease. Semin Dial 2012; 25: 539–44.
- 16Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briët E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47: 2066–71.
- 17Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007; 47: 28–40.
- 18Rourk A, Squires JE. Implications of the Kidd blood group system in renal transplantation. Immunohematology 2012; 28: 91–4.
- 19Sanford KW, Bourikian S, McClain A, Curtis K. Development and Detection of Kidd Antibodies. Lab Med 2015; 46: 235–40.
- 20Watorek E, Boratyńska M, Hałoń A, Klinger M. Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient. Ann Transplant 2008; 13: 48–52.
- 21Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003; 75: 1496–500.
- 22Thakral B, Saluja K, Sharma R, Marwaha N. Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci 2010; 43: 17–22.
- 23Goss C, Avecilla ST, Garbaini J, Degtyaryova D, Lo D, Chang DY, et al. Can the interval between antibody identifications be increased for alloimmunized patients? Transfusion 2016; 56: 334–8.
- 24Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, et al. Red-blood-cell alloimmunisation in relation to antigens’ exposure and their immunogenicity: a cohort study. Lancet Haematol 2016; 3: e284–92.
- 25Schonewille H, Honohan Á, van der Watering LM, Hudig F, Te Boekhorst PA, Koopman-van Gemert AW, et al. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study). Transfusion 2016; 56: 311–20.
